241 related articles for article (PubMed ID: 10613016)
1. [Diagnosis of transmissible spongiform encephalopathies in Spain. Population perspective].
Cuadrado N; Ruiz-Bremón A; Gonzalo I; Plitt C; Redondo Y; Rábano A; Tabernero C; García de Yébenes J; de Pedro Cuesta J
Neurologia; 1999 Nov; 14(9):429-36. PubMed ID: 10613016
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
3. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
Zaborowski A
Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
[TBL] [Abstract][Full Text] [Related]
5. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
Hsich G; Kenney K; Gibbs CJ; Lee KH; Harrington MG
N Engl J Med; 1996 Sep; 335(13):924-30. PubMed ID: 8782499
[TBL] [Abstract][Full Text] [Related]
6. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
7. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
[TBL] [Abstract][Full Text] [Related]
8. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
Sáiz A; Marín C; Tolosa E; Graus F
Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794
[TBL] [Abstract][Full Text] [Related]
10. Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study.
Gelpi E; Heinzl H; Hoftberger R; Unterberger U; Strobel T; Voigtlander T; Drobna E; Jarius C; Lang S; Waldhor T; Bernheimer H; Budka H
Neuroepidemiology; 2008; 30(4):215-21. PubMed ID: 18424902
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007.
Shi Q; Gao C; Zhou W; Zhang BY; Chen JM; Tian C; Jiang HY; Han J; Xiang NJ; Wang XF; Gao YJ; Dong XP
BMC Public Health; 2008 Oct; 8():360. PubMed ID: 18928564
[TBL] [Abstract][Full Text] [Related]
12. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
[TBL] [Abstract][Full Text] [Related]
13. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
[TBL] [Abstract][Full Text] [Related]
14. [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].
Dervaux A; Vicart S; Lopes F; Le Borgne MH
Encephale; 2001; 27(2):194-7. PubMed ID: 11407273
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
[TBL] [Abstract][Full Text] [Related]
16. [The future and problems of vigilance in Creutzfeldt-Jakob disease].
de Pedro Cuesta J
Rev Neurol; 2000 Jul 16-31; 31(2):167-70. PubMed ID: 10951677
[TBL] [Abstract][Full Text] [Related]
17. [Neuroimaging in the diagnosis of human transmissible spongiform encephalopathies].
Moreno F; Arriola Larrarte L
Neurologia; 2006 Oct; 21(8):428-36. PubMed ID: 17013788
[TBL] [Abstract][Full Text] [Related]
18. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of Creutzfeldt-Jakob disease in France, 1992-1995].
Ruffié A; Delasnerie-Lauprêtre N; Brandel JP; Jaussent I; Dormont D; Laplanche JL; Hauw JJ; Richardson S; Alpérovitch A
Rev Epidemiol Sante Publique; 1997 Dec; 45(6):448-53. PubMed ID: 9496575
[TBL] [Abstract][Full Text] [Related]
20. Creutzfeldt-Jakob disease: an emergency department presentation of a rare disease.
Prince LA; Mann D; Reilly T
J Emerg Med; 2006 Jul; 31(1):41-4. PubMed ID: 16798153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
